Archive for category DPP-4 Inhibitors

DPP-4 Inhibitora like Saxagliptin and Alogliptin may increase the Risk of Heart Failure

A U.S. Food and Drug Administration (FDA) safety review has found that type 2 diabetes medicines containing saxagliptin and alogliptin may increase the risk of heart failure, particularly in patients who already have heart or kidney disease. Heart failure can result in the heart not being able to pump enough blood to meet the body’s […]

Leave a comment